| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.1995.13.9.2379 |
| P953 | full work available at URL | http://intl.jco.org/cgi/content/abstract/13/9/2379 |
| https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1995.13.9.2379 | ||
| P698 | PubMed publication ID | 7666097 |
| P50 | author | Amit M Oza | Q90647589 |
| P2093 | author name string | S. Arnott | |
| R. K. Gupta | |||
| D. Crowther | |||
| P. M. Wilkinson | |||
| R. D. James | |||
| D. P. Deakin | |||
| J. A. Radford | |||
| A. Z. Rohatiner | |||
| W. D. Ryder | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2379-2385 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease | |
| P478 | volume | 13 |
| Q40858576 | Anthracyclines in haematology: pharmacokinetics and clinical studies |
| Q40712492 | Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). |
| Q28365255 | ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial |
| Q34547568 | Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy |
| Q33947871 | Current treatment of Hodgkin's disease |
| Q43679244 | Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856. |
| Q36620393 | Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes |
| Q41909027 | High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables |
| Q36419964 | Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy |
| Q77799714 | Radiotherapy considerations in patients with Hodgkin's disease who receive mediastinal radiotherapy and anthracycline-containing chemotherapy |
| Q38506223 | The GHSG Approach to Treating Hodgkin's Lymphoma |
| Q33862700 | The Role of Adjuvant Radiation Therapy for Stages III and IV Hodgkin's Disease |
| Q73315349 | [Oncology '96] |
Search more.